Goldman Sachs
VIRX

Goldman Sachs’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-27,090
Closed -$6.27K 5196
2024
Q3
$6.27K Buy
+27,090
New +$6.27K ﹤0.01% 4755
2022
Q4
Sell
-117,493
Closed -$502K 5390
2022
Q3
$502K Sell
117,493
-86,671
-42% -$370K ﹤0.01% 4234
2022
Q2
$792K Buy
204,164
+53,475
+35% +$207K ﹤0.01% 4104
2022
Q1
$717K Sell
150,689
-41,562
-22% -$198K ﹤0.01% 4352
2021
Q4
$702K Buy
192,251
+21,057
+12% +$76.9K ﹤0.01% 4281
2021
Q3
$1.37M Sell
171,194
-90,319
-35% -$724K ﹤0.01% 3762
2021
Q2
$2.97M Sell
261,513
-342,461
-57% -$3.88M ﹤0.01% 3195
2021
Q1
$5.59M Buy
603,974
+572,585
+1,824% +$5.3M ﹤0.01% 2583
2020
Q4
$62K Buy
31,389
+19,257
+159% +$38K ﹤0.01% 4531
2020
Q3
$15K Buy
12,132
+480
+4% +$593 ﹤0.01% 4395
2020
Q2
$3K Buy
+11,652
New +$3K ﹤0.01% 4341
2018
Q2
Sell
-162,198
Closed -$441K 4345
2018
Q1
$441K Buy
+162,198
New +$441K ﹤0.01% 3544
2016
Q3
Sell
-52,822
Closed -$29K 4661
2016
Q2
$29K Buy
52,822
+92
+0.2% +$51 ﹤0.01% 4348
2016
Q1
$28K Sell
52,730
-11,252
-18% -$5.98K ﹤0.01% 4328
2015
Q4
$57K Sell
63,982
-55,353
-46% -$49.3K ﹤0.01% 4149
2015
Q3
$97K Sell
119,335
-446,785
-79% -$363K ﹤0.01% 4175
2015
Q2
$1.7M Buy
566,120
+437,383
+340% +$1.32M ﹤0.01% 2665
2015
Q1
$315K Buy
128,737
+4,861
+4% +$11.9K ﹤0.01% 3606
2014
Q4
$316K Buy
123,876
+23,805
+24% +$60.7K ﹤0.01% 3665
2014
Q3
$715K Buy
100,071
+80,394
+409% +$574K ﹤0.01% 3112
2014
Q2
$128K Sell
19,677
-52,795
-73% -$343K ﹤0.01% 4132
2014
Q1
$479K Sell
72,472
-192,710
-73% -$1.27M ﹤0.01% 3396
2013
Q4
$1.26M Buy
265,182
+242,842
+1,087% +$1.15M ﹤0.01% 2925
2013
Q3
$111K Buy
22,340
+7,325
+49% +$36.4K ﹤0.01% 4000
2013
Q2
$78K Buy
+15,015
New +$78K ﹤0.01% 3836